Angle logo

AGL - Angle Share Price

88.42p 1.4  1.6%

Last Trade - 8:33am

Sector
Healthcare
Size
Small Cap
Market Cap £187.3m
Enterprise Value £175.1m
Revenue £581k
Position in Universe 848th / 1809
Bullish
Bearish
Unlock AGL Revenue
Momentum
Relative Strength (%)
1m +9.15%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -11.2%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2014 2015 2016 2017 2018 2019 2020E 2021E CAGR / Avg
0.000 0.36 0.50 0.63 0.68 0.58 1.50 0.60
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the six months ended 30 June 2020, ANGLE plcrevenues totaled £235K. Net loss totaled to £4.8M. Resultsare not comparable due to year end change.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Latest News & Insights for AGL
Graphical History

Revenue

AGL Revenue Unlock AGL Revenue

Net Income

AGL Net Income Unlock AGL Revenue

Normalised EPS

AGL Normalised EPS Unlock AGL Revenue

PE Ratio Range

AGL PE Ratio Range Unlock AGL Revenue

Dividend Yield Range

AGL Dividend Yield Range Unlock AGL Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
AGL EPS Forecasts Unlock AGL Revenue
Profile Summary

ANGLE plc is a holding company. The Company's principal activity is undertaken in relation to the commercialization of its Parsortix cell separation system, with deployment in non-invasive cancer diagnostics. The Company is a specialist medical diagnostic company, which offers products for cancer diagnostics and fetal health. Its Parsortix cell separation system uses a microfluidic technology in the form of a one-time use cassette to capture and then harvest circulating tumor cells (CTCs) from blood. The cassette captures CTCs based on their less deformable nature and larger size compared to other blood components. The resulting liquid biopsy (blood test) enables the detection and investigation of mutations in the patient's cancer for personalized cancer care. The harvested CTCs have a range of applications, including diagnosis, prognosis, mutational analysis and drug selection, drug development, assessment of treatment effectiveness and remission monitoring.

Directors
Last Annual December 31st, 2019
Last Interim June 30th, 2020
Incorporated December 4, 2003
Public Since March 17, 2004
No. of Shareholders: n/a
No. of Employees: 87
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index FTSE Aim All Share ,
Exchange London Stock Exchange (AIM)
Shares in Issue 215,291,919
Free Float (0.0%)
Eligible for
ISAs
SIPPs
AGL Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for AGL
Upcoming Events for AGL
Frequently Asked Questions for Angle
What is the Angle share price?

As of 8:33am, shares in Angle are trading at 88.42p, giving the company a market capitalisation of £187.3m. This share price information is delayed by 15 minutes.

How has the Angle share price performed this year?

Shares in Angle are currently trading at 88.42p and the price has moved by 33.85% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Angle price has moved by 39.41% over the past year.

What are the analyst and broker recommendations for Angle?

Of the analysts with advisory recommendations for Angle, there are there are currently 0 "buy" , 1 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Angle is Hold. You can view the full broker recommendation list by unlocking its StockReport.

When will Angle next release its financial results?

Angle is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-06-30
What is the Angle dividend yield?

Angle does not currently pay a dividend.

Does Angle pay a dividend?

Angle does not currently pay a dividend.

When does Angle next pay dividends?

Angle does not currently pay a dividend.

How do I buy Angle shares?

To buy shares in Angle you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Angle?

Shares in Angle are currently trading at 88.42p, giving the company a market capitalisation of £187.3m.

Where are Angle shares listed? Where are Angle shares listed?

Here are the trading details for Angle:

Country of listing: United Kingdom
Exchange: LSE
Ticker Symbol: AGL
What kind of share is Angle?

Based on an overall assessment of its quality, value and momentum, Angle is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Angle share price forecast 2021?

Shares in Angle are currently priced at 88.42p. At that level they are trading at 72.41% discount to the analyst consensus target price of 320.48.

Analysts covering Angle currently have a consensus Earnings Per Share (EPS) forecast of -0.066 for the next financial year.

How can I tell whether the Angle share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Angle. Over the past six months, the relative strength of its shares against the market has been 37.53%. At the current price of 88.42p, shares in Angle are trading at 52.76% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Angle PE Ratio?

We were not able to find PE ratio data for Angle.

Who are the key directors of Angle?

Angle's management team is headed by:

Andrew Newland - CEO
Ian Griffiths - FID
David Quysner - NID
Garth Selvey - NEC
Brian Howlett - NED
Jan Groen - NED
Who are the major shareholders of Angle?

Here are the top five shareholders of Angle based on the size of their shareholding:

Keane (Dermot A) Individual Investor
Percentage owned: 5.93% (12.8m shares)
Conifer Management LLC Hedge Fund
Percentage owned: 5.59% (12.0m shares)
Morgan Stanley Investment Management Ltd. (UK) Investment Advisor
Percentage owned: 5.32% (11.5m shares)
Jupiter UK Growth Fund Mutual Fund
Percentage owned: 5.12% (11.0m shares)
Legal & General Investment Management Ltd. Investment Advisor/Hedge Fund
Percentage owned: 4.81% (10.4m shares)
Similar to AGL
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.